Skip to Content

A/P 25/15 (Oseni 25 mg / 15 mg)

Generic Name: alogliptin/pioglitazone

Pill with imprint A/P 25/15 is Yellow, Round and has been identified as Oseni 25 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

Oseni is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Oseni 25 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A/P 25/15

Oseni

Generic Name:
alogliptin/pioglitazone
Imprint:
A/P 25/15
Strength:
25 mg / 15 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Takeda Pharmaceuticals America, Inc.
Inactive Ingredients:
mannitol
hydroxypropyl cellulose (type l)
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
hypromellose 2910 (6 mPa.s)
titanium dioxide
polyethylene glycol 8000
magnesium silicate
lactose monohydrate
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide